THE GORDON WILSON LECTURE: THE ETHICS OF HUMAN GENOME EDITING.
Level 5 - mechanism / opinion, no new human data
Narrative lecture and expert ethical commentary without primary empirical data
What was done
This published lecture analyzed the ethical and regulatory landscape of human genome editing. It evaluated somatic versus germline modifications, reviewed the 2017 National Academy of Sciences and National Academy of Medicine criteria for risk acceptance in preventing inherited disorders, and assessed ethical distinctions surrounding human enhancement.
What was found
The abstract reports no empirical numbers or quantitative findings. It establishes that somatic genome editing is governed by existing gene therapy frameworks, while germline editing remains contentious without consensus. It highlights concerns regarding unintended consequences for people with genetic variants and proposes evaluating enhancements through the lens of unfair advantage.
Why it matters
The paper outlines the conceptual boundaries between accepted therapeutic somatic gene modifications and unresolved ethical challenges in germline editing and human enhancement.
Limits
This is a narrative lecture and conceptual ethical analysis containing no clinical trials, experimental data, or systematic review methodology.
Cited by
- supports Somatic genetic edits modify DNA in individual cells such that genetic consequences are passed on to daughter cells within the individual, but are not passed on to the next generation of humans because sperm and egg cells are not edited.